Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Anormed Ord (MM) (ANOR)
Anormed Ord (MM) (ANOR) News

ANOR

Anormed Ord (MM) (ANOR)

Anormed Ord (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANOR

1

Date	Time	Source	Headline	Symbol	Company
11/07/2006	4:57PM	PR Newswire (US)	Genzyme Completes Tender Offer for Outstanding Shares of AnorMED	NASDAQ:ANOR
11/07/2006	12:01AM	PR Newswire (US)	Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review	NASDAQ:ANOR
11/03/2006	12:05AM	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
11/03/2006	12:05AM	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
10/26/2006	10:00AM	PR Newswire (US)	Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer	NASDAQ:ANOR	Anormed Ord (MM)
10/23/2006	10:00AM	PR Newswire (US)	AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule	NASDAQ:ANOR
10/17/2006	10:47AM	PR Newswire (US)	AnorMED and Genzyme reach agreement on acquisition	NASDAQ:ANOR
10/11/2006	10:03PM	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
10/11/2006	9:47PM	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
10/11/2006	12:30AM	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
10/11/2006	12:30AM	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
10/10/2006	10:50AM	PR Newswire (US)	Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash	NASDAQ:ANOR
10/06/2006	12:41PM	PR Newswire (US)	Genzyme Extends Deadline for Tender Offer to Acquire AnorMED Inc.	NASDAQ:ANOR	Anormed Ord (MM)
10/05/2006	11:10PM	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
10/05/2006	11:10PM	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
10/05/2006	12:36AM	PR Newswire (US)	AnorMED board continues to recommend that shareholders accept Millennium's planned tender offer	NASDAQ:ANOR
09/26/2006	10:46AM	PR Newswire (US)	Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date	NASDAQ:ANOR
09/26/2006	10:45AM	PR Newswire (US)	AnorMED agrees to support a planned tender offer of US$12 per share from Millennium Pharmaceuticals	NASDAQ:ANOR
09/25/2006	1:23AM	PR Newswire (US)	Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
09/20/2006	10:00AM	PR Newswire (US)	AnorMED reports on Annual General Meeting	NASDAQ:ANOR
09/19/2006	8:30AM	PR Newswire (US)	AnorMED amends license agreement for cancer drug	NASDAQ:ANOR
09/19/2006	8:30AM	PR Newswire (US)	Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Cond	NASDAQ:ANOR
09/18/2006	10:00AM	PR Newswire (US)	Approval of FOSRENOL in Germany triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
09/15/2006	9:22PM	PR Newswire (US)	AnorMED Provides Update on Limited Duration Shareholder Rights Plan	NASDAQ:ANOR
09/12/2006	1:57PM	PR Newswire (US)	Atticus Capital LP Opposes Genzyme bid for AnorMED	NASDAQ:ANOR

Showing the most relevant articles for your search:NASDAQ:ANOR

1

Code Green Apparel (PK)

1812 Brewing (PK)

Moon Equity (PK)

Bell Buckle (PK)

Anavex Life Sciences

Digital Brand Media and ... (PK)

Good Vibrations Shoes (PK)

AMC Entertainment

Intergrated Cannabis Sol... (PK)

Hannover House (PK)

Rennova Health (PK)

Voip Pal Com (QB)

Trump Media and Technology

Delayed Upgrade Clock